It is noteworthy that these three patients did not show particular clinical characteristics, and did not show germline or somatic mutation either of the gene POLE, or of one of the genes involved in DNA mismatch repair (MMR) or in homologous recombination deficiency (HRD). This evidence concerns the gene POLE and hypoparathyroidism-retardation-dysmorphism syndrome.